Having a larger brain tumor at diagnosis is associated with a higher risk of death, longer hospital stays, and greater neurological deficits, a study suggests.

Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis on track for the third quarter of 2025.

Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

In a 286-patient Phase 2 trial, elraglusib combined with gemcitabine/nab-paclitaxel achieved a statistically significant ...

Foley did not direct "Fifty Shades of Grey", but did join the franchise to direct both its sequels, "Fifty Shades Darker" and "Fifty Shades Freed", after the departure of Sam Taylor-Johnson following ...

The development of second tumors is influenced by several factors. These include the type and intensity of treatment received ...

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system more effectively than traditional therapies, particularly against evasive and ...

Check out the latest oncology news from this week, including highlights from the 2025 American Association for Cancer Research and American Urological Association annual meetings.

The anti-GD2 therapy naxitamab has been included in the NCCN Clinical Practice Guidelines in Oncology for the treatment of ...

ImmunityBio's sBLA for Anktiva was unexpectedly rejected by the FDA, contradicting prior positive feedback and approval for a ...

Sakit kepala saat hamil umumnya terjadi saat trimester pertama dan trimester ketiga. Apakah saat ini Bunda ada yang sedang ...